Treatment of fibromyalgia

Patent 4877798 Issued on October 31, 1989. Estimated Expiration Date:

October 18, 2008. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Inventor

Sorensen, Stephen M.

Assignee

Merrell Dow Pharmaceuticals Inc.

Application

No. 262168 filed on 10/18/1988

US Classes:

514/317Additional ring containing

Examiners

Primary: Friedman, Stanley J.

Attorney, Agent or Firm

Dixon; J. Michael

International Class

A61K 031/445

Abstract

The present invention relates to a method for relieving or alleviating the symptomatology associated with fibromyalgia comprising administering to a patient a compound as described by Formula I.

Other References

Chem. Abst. 106-156281U (1987)
Fibromyalgia Syndrome An Emerging but Controversial Condition, JAMA, May 22/29, 1987, vol. 257 No. 20, p. 2782, Don L. Goldenberg, M.D
Current Issues Concerning Management of the Fibrositis/Fibromyalgia Syndrome, The American Journal of Medicine, vol. 81 (suppl 3A) p. 15, Sep. 29, 1986, Robert Bennett, M.D
The Clinical Syndrome of Fibrositis, The American Journal of Medicine, vol. 81 (suppl 3A) p. 7, Sep. 26, 1986, Frederick Wolfe, M.D
U.S. Patent Application Ser. No. 71,524 which was filed on Jul. 7, 1987 by A. Carr, et a